Zaid S Al-Kadhimi, MD

Associate Professor

  • 555 Citations
  • 14 h-Index
20042018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Graft vs Host Disease Medicine & Life Sciences
Transplants Medicine & Life Sciences
Tacrolimus Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Melphalan Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

  • 555 Citations
  • 14 h-Index
  • 28 Article
  • 8 Review article
  • 3 Letter

A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

Modi, D., Al-Kadhimi, Z., Chen, W., Jang, H., Deol, A., Ayash, L., Bhutani, D., Alavi, A., Ratanatharathorn, V. & Uberti, J. P., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. E96-E98

Research output: Contribution to journalLetter

Cell Transplantation
Tacrolimus
Graft vs Host Disease
thymoglobulin
1 Citations

Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Hosoba, S., Waller, E. K., Shenvi, N., Graiser, M., Easley, K. A., Al-Kadhimi, Z., Andoh, A., Antun, A. G., Barclay, S., Josephson, C. D., Koff, J. L., Khoury, H. J., Langston, A. A., Zimring, J. C., Roback, J. D. & Giver, C. R., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Erythrocyte Transfusion
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Erythrocytes
Confidence Intervals
8 Citations

Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

Khoury, H. J., Langston, A. A., Kota, V. K., Wilkinson, J. A., Pusic, I., Jillella, A., Bauer, S., Kim, A. S., Roberts, D., Al-Kadhimi, Z., Bodo, I., Winton, E., Arellano, M. & DiPersio, J. F., Jan 24 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-6 6 p.

Research output: Contribution to journalArticle

Graft vs Host Disease
Steroids
Janus Kinases
Allografts
Lung
1 Citations

Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors

Defilipp, Z., Rosand, C. B., Goldstein, D. A., Master, V. A., Carthon, B. C., Harris, W. B., Kucuk, O., Al-Kadhimi, Z., Cohen, J. B., Flowers, C. R., Lechowicz, M. J., Nooka, A. K., Kaufman, J. L., Langston, A. A., Chen, Z., Arora, J. & Waller, E. K., Jan 1 2017, In : Bone Marrow Transplantation. 52, 1, p. 132-134 3 p.

Research output: Contribution to journalLetter

Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention

Al-Kadhimi, Z., Gul, Z., Abidi, M., Lum, L. G., Deol, A., Chen, W., Jang, H., Ozust, C., Langston, A., Waller, E. & Uberti, J., Sep 1 2017, In : Bone Marrow Transplantation. 52, 9, p. 1304-1310 7 p.

Research output: Contribution to journalArticle

Tacrolimus
Sirolimus
Transplants
Mortality
Incidence